AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours
Completed
- Conditions
- Major Depressive DisordersSchizophreniaBipolar Disorders
- First Posted Date
- 2011-06-22
- Last Posted Date
- 2011-06-28
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 221
- Registration Number
- NCT01377896
Recurrence Rate, Risk Factors for the Recurrence, and Quality of Life in Patients With GERD in Korea-an Observational
Completed
- Conditions
- The Aim of This Study is to Investigate the Frequency and Related Risk Factors of Recurrence, and Quality of Life in Patients With GERD After Treatment With PPI
- First Posted Date
- 2011-06-22
- Last Posted Date
- 2013-10-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 855
- Registration Number
- NCT01378338
- Locations
- 🇰🇷
Research Site, Seoul, Korea, Republic of
Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Russia
Completed
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2011-06-15
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 600
- Registration Number
- NCT01373957
- Locations
- 🇷🇺
Research Site, Tyumen, Russian Federation
🇷🇺Research site, Tomsk, Russian Federation
Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function
Phase 1
Completed
- Conditions
- Renal Impairment
- Interventions
- First Posted Date
- 2011-06-14
- Last Posted Date
- 2014-10-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 32
- Registration Number
- NCT01372826
- Locations
- 🇺🇸
Research Site, Overland Park, Kansas, United States
Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea
Completed
- Conditions
- Dyslipidemia
- First Posted Date
- 2011-06-14
- Last Posted Date
- 2011-12-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 4950
- Registration Number
- NCT01372956
- Locations
- 🇰🇷
Research Site, Seoul, Korea, Republic of
The Predictors for Asthma Control by Stepwise Treatment During 6 Months in Korean Elderly
Completed
- Conditions
- Asthma
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2013-01-14
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 297
- Registration Number
- NCT01370577
- Locations
- 🇰🇷
Research Site, Changwon, Gyeonsangnam-do, Korea, Republic of
Efficacy of Esomeprazole in Patients With Frequent Heartburn
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2013-04-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 341
- Registration Number
- NCT01370538
- Locations
- 🇺🇸
Research site, West Jordan, Utah, United States
Efficacy of Esomeprazole in Patients With Frequent Heartburn
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2013-03-14
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 340
- Registration Number
- NCT01370525
- Locations
- 🇺🇸
Research site, San Antonio, Texas, United States
Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease
Completed
- Conditions
- AsthmaChronic Obstructive Pulmonary Disease
- First Posted Date
- 2011-06-09
- Last Posted Date
- 2013-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 20000
- Registration Number
- NCT01369810
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis
Completed
- Conditions
- Seasonal RhinitisPerennial Rhinitis
- First Posted Date
- 2011-06-09
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1630
- Registration Number
- NCT01369563
- Locations
- 🇲🇽
Yasmín Crespo, Naucalpan de Juarez, Estado de Mexico, Mexico